Other Headlines

The medical community pays tribute to a dedicated crew.
Advocacy groups applaud passage of bill that would permanently repeal and replace SGR.
DOTmed discusses the American Society for Therapeutic Radiation Oncology (ASTRO) program for public awareness with ASTRO's assistant director of communications, Beth Bukata.
A novel microfluidic drug delivery system makes it possible to reach parts of the body poorly served by oral and injectable medications.
The "germ theory" of schizophrenia got a mild boost this week as scientists discover that recently afflicted schizophrenics show higher levels of inflammatory proteins in the brain.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More Industry Headlines

House Passes Medicare Physician Payment Reform Act Advocacy groups applaud passage of bill that would permanently repeal and replace SGR.

Aural Trumps Oral for Ear Treatment A novel microfluidic drug delivery system makes it possible to reach parts of the body poorly served by oral and injectable medications.

Scientists Find Unusual Immune System Activity in Brains of Schizophrenics The "germ theory" of schizophrenia got a mild boost this week as scientists discover that recently afflicted schizophrenics show higher levels of inflammatory proteins in the brain.

Clinical PET-MRI Moves Closer to Reality Thanks to a European grant for the HyperIMAGE project, a consortium of scientists across Europe have worked with Philips to develop a proof-of-concept, pre-clinical combined MR-PET scanner that could one day lead to improved radiation therapy and cardiology treatments.

Senate Health Care Reform Bill Unveiled Legislation may go to cloture vote this weekend. Read the details.

RSNA 2009 Preview This year's RSNA should provide a very interesting look at the effects of the economy on the major OEMs. As always, vendors are whipping up the hoopla, and inside this story are great previews of what's being debuted. But DOTmed reporters will also be there to get the real buzz. Look for video interviews in our Online News direct from the show.

Interview With Fred Robertson, President & CEO of TomoTherapy TomoTherapy president and CEO Fred Robertson talks with DOTmed about his perspective on ASTRO's 2009 annual meeting, changes in the radiation oncology industry and two important TomoTherapy product launches that occurred at the show. Watch the HD video.

Health Care Reform Round-Up: CBO Pegs Senate Bill at $849 Billion The numbers are in on the Senate's version of reform. Also read about the wide-ranging impact that the legislation would have.

Pen-Sized Microscope Aims for Precise Brain Surgeries A confocal microscope picking up brain-safe fluorescent dyes could result in more accurate and streamlined surgeries to remove tumors from the brain.

U.S. Preventive Services Task Force Has Stunning New Guidelines on Mammography Agency recommends no routine screening for women 40-49, no self-examination. Read the details.

Every major hospital in the U.S.
has a nuclear medicine department

Identifying the Nuclear in Nuclear Medicine as High Benefit

by Barbara Kram, Editor
RESTON, Va. Say the word nuclear and it conjures up mistaken ideas about radiation, an invisible, odorless and intangible force that allows doctors to non-invasively see into the body. Say the words nuclear medicine, and its powerful reality is that it is highly beneficial to life, said Jonathan M. Links, former SNM president, who has written an overview on understanding radiological and nuclear terrorism in the October issue of the Journal of Nuclear Medicine.

When people hear the words radiation and radioactivity, they initially think negative thoughts, said Links, professor and director of the Center for Public Health Preparedness at Johns Hopkins Bloomberg School of Public Health in Baltimore, Md. The publics perception of the risks of radiation is that radiation is highly risky. Its best to get the scientific facts. In reality, radiationa release of energyallows doctors to effectively diagnose and treat disease, noted Baltimores radiation terror expert and co-author of Understanding Radiological and Nuclear Terrorism as Public Health Threats: Preparedness and Response Perspectives.

The use of nuclear medicinegiving tiny amounts of radioactive materials to patients to examine molecular processes in the body to diagnose and treat a variety of diseasescontinues to grow and evolve. Every major hospital in this country has a nuclear medicine department. Last year, 19.7 million nuclear medicine procedures were performed on 17.2 million women, men and children in more than 7,200 medical sites in the United Statesa 15 percent increase from four years ago. Every day, about 55,000 women, men and children undergo nuclear medicine (also called molecular imaging) procedures to evaluate heart disease, detect cancer and determine response to treatment, diagnose and evaluate brain disorders and locate stress fractures.

When it comes to nuclear medicine, Links says the public should keep in mind these facts.

* Nuclear medicine/molecular imaging procedures are an invaluable way to gather medical information that would otherwise be unavailable, require surgery or necessitate more expensive diagnostic tests.
* The radiation dose to the body a patient may receive from a diagnostic nuclear medicine study is typically equal to or less than the natural background radiation dose a person may receive every year from rocks, soil, space (air travel), building materials and radon.
* In use for more than 60 years, nuclear medicine is an established medical specialty that is older than CT, MRI and ultrasound imaging. As nuclear medicine techniques merge with new technologies, hybrid imaging and advances in molecular biology, a new era in molecular imaging will add to the understanding of the molecular basis of disease. Molecular imaging will provide a way to integrate information about location, structure, function and biology, leading to a new package of noninvasive imaging tools that could have vast potential for improving patient care.
* Terrorists use the threat of radiationof setting off a dirty bomb (radioactivity packaged with conventional explosives) or an improvised (crude) nuclear deviceto create a climate of fear, says Links. From a public health perspective, this is more a psychological weapon than a physical weapon for a community. Radiation is an especially powerful terrorism weapon because it instills considerable fear, notes Links. To counter the terror of terrorism, Links suggests integrating excellent crisis communication with every disaster plan created. Public safety and health officials need to communicate with the public about what safeguards are in place to prevent terrorist actions and what plans and infrastructure are in place to rapidly respond to the publics needs. Terrorists succeed if we give in to the fear because thats what they want. Their target isnt those who may get injured or killed in an explosionits all the rest of us, said Links.
* Nuclear medicine professionals are knowledgeable about the uses and effects of radiation, and should assist with local police, fire, public safety and health departments in developing community response plans to ensure that local and federal first responders can address issues or circumstances linked to possible terrorist attacks. Links, who works with officials from the Centers for Disease Control and Prevention and the Department of Homeland Security, encourages nuclear medicine professionals to contact local authorities and become identified as subject matter experts. All preparedness starts locally, said Links. Nuclear medicine professionals should actively seek out such collaboration and be part of planning and preparedness activities now, he said.
* Given heightened concerns about terrorism, sensitive radiation detectors are used in major cities and public transportation facilities. Individuals who receive nuclear medicine procedures may trigger detector alarms and be stopped by security personnel. Common radioisotopes that are used in many nuclear medicine studies that could set off radiation monitors, each with varying half lives or decay time, include technetium-99m, fluorine-18 (FDG) and thallium-201. Most recent problems with radiation monitors have been with the use of iodine-131, which is used to treat hyperthyroidism, thyroid cancer and lymphoma.
* Your physician can help you avoid any security problems by providing a letter containing the following information: the patients name, name and date of the nuclear medicine procedure, the related radionuclide, its half life, the administered activity and 24-hour contact information. This letter should provide specific details about who should be contacted. Outside of normal working hours, the contact person should have access to an appropriate source of information so the information in the letter can be independently confirmed.

Understanding Radiological and Nuclear Terrorism as Public Health Threats: Preparedness and Response Perspectives appears in the October issue of the Journal of Nuclear Medicine, which is published by SNM, an international scientific and professional organization of more than 16,000 physician, technologist and scientist members. Other co-authors include Daniel J. Barnett and Cindy L. Parker, both Johns Hopkins Center for Public Health Preparedness; Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.; David W. Blodgett, Southwest Utah Public Health Department, St. George, Utah, and Johns Hopkins Center for Public Health Preparedness, Baltimore, Md.; and Rachel K. Wierzba, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.

Related Items
Adobe Portable Document Format JNM: "Understanding Radiologic and Nuclear Terrorism as Public Health Threats: Preparedness and Response Perspectives" (.pdf)

Media representatives: To obtain a copy of this article, please contact Maryann Verrillo by phone at (703) 708-9000, ext. 1211, or send an e-mail to mverrillo@snm.org. Current and past issues of the Journal of Nuclear Medicine can be found online at jnm.snmjournals.org. Print copies can be obtained by contacting the SNM Service Center, 1850 Samuel Morse Drive, Reston, VA 20190-5316; phone (800) 513-6853; e-mail servicecenter@snm.org; fax (703) 708-9015. A subscription to the journal is an SNM member benefit.

About SNMAdvancing Molecular Imaging and Therapy
SNM is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of molecular and nuclear imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed journal in the field (the Journal of Nuclear Medicine); host the premier annual meeting for medical imaging; sponsor research grants, fellowships and awards; and train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances. SNM members have introducedand continue to explorebiological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at www.snm.org.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED